Tenaya Therapeutics Inc
NASDAQ:TNYA
Cash Flow Statement
Cash Flow Statement
Tenaya Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||
Net Income |
(38)
|
(42)
|
(49)
|
(57)
|
(73)
|
(91)
|
(104)
|
(116)
|
(124)
|
(124)
|
(129)
|
(128)
|
(124)
|
|
Depreciation & Amortization |
2
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
8
|
9
|
9
|
9
|
|
Stock-Based Compensation |
1
|
1
|
2
|
3
|
3
|
5
|
7
|
9
|
11
|
13
|
14
|
15
|
0
|
|
Other Non-Cash Items |
1
|
1
|
2
|
3
|
4
|
6
|
9
|
11
|
14
|
15
|
15
|
16
|
19
|
|
Change in Working Capital |
(0)
|
(4)
|
(3)
|
(4)
|
5
|
7
|
4
|
2
|
(1)
|
(4)
|
(1)
|
0
|
(6)
|
|
Cash from Operating Activities |
(35)
N/A
|
(43)
-21%
|
(48)
-11%
|
(55)
-15%
|
(61)
-11%
|
(74)
-21%
|
(87)
-18%
|
(98)
-12%
|
(104)
-6%
|
(106)
-1%
|
(107)
-1%
|
(103)
+4%
|
(102)
+1%
|
|
Investing Cash Flow | ||||||||||||||
Capital Expenditures |
(10)
|
(14)
|
(16)
|
(21)
|
(25)
|
(29)
|
(33)
|
(32)
|
(21)
|
(13)
|
(6)
|
(2)
|
(1)
|
|
Other Items |
3
|
0
|
0
|
(163)
|
(213)
|
(188)
|
(151)
|
47
|
104
|
88
|
76
|
71
|
50
|
|
Cash from Investing Activities |
(7)
N/A
|
(14)
-95%
|
(16)
-16%
|
(184)
-1 058%
|
(239)
-30%
|
(218)
+9%
|
(184)
+15%
|
15
N/A
|
84
+454%
|
75
-10%
|
70
-7%
|
70
-1%
|
49
-30%
|
|
Financing Cash Flow | ||||||||||||||
Net Issuance of Common Stock |
147
|
137
|
137
|
295
|
209
|
189
|
189
|
0
|
78
|
78
|
78
|
78
|
1
|
|
Other |
0
|
0
|
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
(1)
|
3
|
3
|
3
|
|
Cash from Financing Activities |
147
N/A
|
137
-7%
|
135
-1%
|
295
+118%
|
209
-29%
|
189
-10%
|
191
+1%
|
0
-100%
|
78
+29 812%
|
77
-1%
|
81
+5%
|
81
N/A
|
4
-95%
|
|
Change in Cash | ||||||||||||||
Net Change in Cash |
105
N/A
|
80
-24%
|
72
-10%
|
56
-22%
|
(90)
N/A
|
(103)
-14%
|
(81)
+21%
|
(83)
-2%
|
57
N/A
|
47
-18%
|
45
-4%
|
48
+8%
|
(49)
N/A
|
|
Free Cash Flow | ||||||||||||||
Free Cash Flow |
(45)
N/A
|
(57)
-25%
|
(64)
-12%
|
(76)
-19%
|
(86)
-14%
|
(103)
-20%
|
(121)
-17%
|
(130)
-8%
|
(125)
+4%
|
(119)
+5%
|
(112)
+5%
|
(104)
+7%
|
(103)
+1%
|